2021-yilning may oyida Moderna va Samsung Biologics Moderna COVID-19 vaktsinasini to‘ldiruvchi ishlab chiqarish bo‘yicha kelishuvni e’lon qilishdi. Shartnoma amalga oshirilgach, Samsung Biologics o'z texnologiyasi va imkoniyatlaridan foydalangan holda umumiy vaqt jadvalini muvaffaqiyatli qisqartirdi, bu esa Moderna kompaniyasining COVID-19 vaktsinasining birinchi partiyasini shartnoma imzolangan kundan boshlab besh oy ichida mahalliy yetkazib berish uchun chiqarish imkonini berdi.
eTurboNews maqolalar faqat obunachilar uchun. Obuna bo'lish BEPUL.
Kirish BEPUL obuna bo'lish uchun shu yerni bosing
Kirish BEPUL obuna bo'lish uchun shu yerni bosing
USHBU MAQOLADAN NIMA OLISH KERAK:
- Upon execution of the deal, Samsung Biologics successfully reduced the overall timeline by leveraging its technology and capabilities, enabling the first batch of Moderna’s COVID-19 vaccine to be released for domestic supply within five months from the signing of the contract.
- In May 2021, Moderna and Samsung Biologics announced the agreement for fill-finish manufacturing of the Moderna COVID-19 vaccine.
- eTurboNews maqolalar faqat obunachilar uchun.
